医学
美罗华
中止
IgG4相关疾病
疾病
免疫学
免疫系统
内科学
抗体
作者
Marco Lanzillotta,John H. Stone,Emanuel Della‐Torre
摘要
ABSTRACT IgG4-related disease (IgG4-RD) is an increasingly recognized immune-mediated fibroinflammatory disorder that promptly responds to glucocorticoids but commonly relapses during steroid tapering or after discontinuation. In the last few years, B-cell depletion therapy with rituximab (RTX) proved to be effective in the induction of remission and maintenance treatment of IgG4-RD, providing a new powerful tool in the management of this emerging condition. In this review, we outline the pathogenetic rationale for using B-cell depleting agents in IgG4-RD, we summarize available clinical experience with RTX in this disease, and we describe future possible therapies targeting B-lymphocytes that are now in the pipeline.
科研通智能强力驱动
Strongly Powered by AbleSci AI